(Q43891479)

27 November 2017

Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test (English)

1 reference

27 November 2017

1

1 reference

27 November 2017

Michelle E Page

2

1 reference

PubMed ID

11858799

27 November 2017

Irwin Lucki

series ordinal

3

1 reference

PubMed ID

11858799

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

European Journal of Pharmacology

27 November 2017

1 reference

27 November 2017

436

1 reference

27 November 2017

197-205

1 reference

27 November 2017

3

1 reference

The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal.

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

DSP-4 treatment produces abnormal tyrosine hydroxylase immunoreactive fibers in rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Is the forced swimming test a suitable model for revealing antidepressant activity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Rationale for the development of noradrenaline reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Acute and chronic effects of the atypical antidepressant, mianserin on brain noradrenergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Alteration of central alpha2- and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt's test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Further evidence that noradrenaline is not involved in the anti-immobility activity of chronic desipramine in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Modulatory role of dopamine on excitatory amino acid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)—A useful denervation tool for central and peripheral noradrenaline neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Evidence for existence of two opposite noradrenergic brain systems controlling behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Effects of lesions of the ventral noradrenergic bundle on aggressive behavior in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Electrophysiological changes accompanying DSP-4 lesions of rat locus coeruleus neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Facilitation of norepinephrine release from cerebral cortex is mediated by beta 2-adrenergic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Modification of behavioral response to intra-hippocampal injections of noradrenaline and adrenoceptor agonists by chronic treatment with desipramine and citalopram: functional aspects of adaptive receptor changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

A stimulatory effect of intraaccumbens injections of noradrenaline on the behavior of rats in the forced swim test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Depression: a new animal model sensitive to antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

The catecholamine hypothesis of affective disorders: a review of supporting evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Central noradrenergic neurones and stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Activation of the locus ceruleus brain noradrenergic system during stress: circuitry, consequences, and regulation.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

7 January 2021

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

7 January 2021

Dissociable effects of lesions to the dorsal or ventral noradrenergic bundle on the acquisition, performance, and extinction of aversive conditioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

7 January 2021

Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901628-4

7 January 2021

10.1016/S0014-2999(01)01628-4

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

11858799